Company : Logopharm

Category : Analytical Equipment

Micro-affinity purification

High Content Antibody Profiling

Even with careful design of epitopes and selection techniques it isimpossible to predict the in-vivo binding properties of antibodies towardsnatively folded proteins. High content antibody profiling through Logopharm's proprietary parallel multi-affinitypurification (PMAP) platform can determine the relative off-targetreactivity, isoform selectivity and target binding efficiency of up to 96antibodies/experiment in a native-like environment. This provides a rational basis for antibody selection and epitope design.

Other Products

Cell surface markers

Protein complexes

Membrane protein tools

Logopharm strategy